SEC14L1 Antibody (YA8762)

Cat. No.: HY-P89078: Data Sheet User Guide for Antibodies
FAQs
Technical Support

SEC14L1 Antibody (YA8762) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SEC14L1.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

사이즈		재고
50 μL		견적 받기
100 μL		견적 받기

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
제품 설명

제품 설명

SEC14L1 Antibody (YA8762) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SEC14L1.

Host

Mouse

Clonality

Monoclonal

Species Reactivity

Human, Mouse, Rat

SwissProt ID

Q92503

Immunogen

Full length human recombinant protein of human SEC14L1 produced in HEK293T cell.

Application &
Dilution Ratio

Application	Dilution Ratio
IHC-P IHC-P: Immunohistochemistry-Paraffin	1:150-500

Sensitivity	Endogenous	Purity	Affinity purified
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG1

Appearance

Liquid

Formulation

Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

선적

Shipping with blue ice.

Background

Function：May play a role in innate immunity by inhibiting the antiviral RIG-I signaling pathway. In this pathway, functions as a negative regulator of RIGI, the cytoplasmic sensor of viral nucleic acids. Prevents the interaction of RIGI with MAVS/IPS1, an important step in signal propagation (PubMed:23843640). May also regulate the SLC18A3 and SLC5A7 cholinergic transporters (PubMed:17092608)

Subcellular Localization：Cytoplasm,Golgi apparatus

Expression：
Tissue_Specificity: Ubiquitous

Isoforms & Post-Translational Modification：Q92503 has three isomers: Q92503-1: 81250 Da (predicted); Q92503-2: 81842 Da (predicted); Q92503-3: 77132 Da (predicted).

Subunit：Interacts with RIGI (via tandem CARD domain); the interaction is direct (PubMed:23843640)

Synonyms

PRELID4A; SEC14L

각종 서류

User Guide for Antibodies (1077 KB)